Transforming Growth Factor-β in Human Diabetic Nephropathy

Abstract

This study demonstrates that over a 2-year period, treatment with perindopril in patients with type 2 diabetes and nephropathy leads to a reduction in both renal TGF-beta1 gene expression and its downstream activation.